{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:35:43Z","timestamp":1772116543208,"version":"3.50.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.semarthrit.2020.12.001","type":"journal-article","created":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T04:13:53Z","timestamp":1608264833000},"page":"121-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["The prevalence of gout and hyperuricaemia in Australia: An updated systematic review"],"prefix":"10.1016","volume":"51","author":[{"given":"K.","family":"Pathmanathan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip C.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.L.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.I.","family":"Keen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2020.12.001_bib0001","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","article-title":"Global epidemiology of gout: prevalence, incidence and risk factors","volume":"11","author":"Kuo","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0002","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1477-7525-10-117","article-title":"Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: results from a cross-sectional survey","volume":"10","author":"Khanna","year":"2012","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0003","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/rheumatology\/ket265","article-title":"Health-related quality of life in gout: a systematic review","volume":"52","author":"Chandratre","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0004","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/annrheumdis-2017-212063","article-title":"Work disability in gout: a population-based case\u2013control study","volume":"77","author":"Sigurdardottir","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0005","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1093\/rheumatology\/kem246","article-title":"Tophaceous joint disease strongly predicts hand function in patients with gout","volume":"46","author":"Dalbeth","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0006","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/annrheumdis-2014-206410","article-title":"Comorbidities in patients with gout prior to and following diagnosis: case-control study","volume":"75","author":"Kuo","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0007","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.amjmed.2011.09.033","article-title":"Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008","volume":"125","author":"Zhu","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0008","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1093\/rheumatology\/ket293","article-title":"Gout as a risk factor for myocardial infarction and stroke in England: evidence from record linkage studies","volume":"52","author":"Seminog","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0009","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13075-015-0610-9","article-title":"Gout and risk of chronic kidney disease and nephrolithiasis: meta-analysis of observational studies","volume":"17","author":"Roughley","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.22466","article-title":"Prevalence of the metabolic syndrome in patients with gout: the third national health and nutrition examination survey","volume":"57","author":"Choi","year":"2007","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0011","article-title":"Bidirectional association between diabetes and gout: the Singapore Chinese health study","volume":"6","author":"Pan","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0012","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11926-011-0234-2","article-title":"Association between gout and all-cause as well as cardiovascular mortality: a systematic review","volume":"14","author":"Lottmann","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0013","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nrrheum.2017.27","article-title":"Risk of premature death in gout unchanged for years","volume":"13","author":"Kuo","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0014","article-title":"Australian institute of health and welfare website","year":"2020","journal-title":"Aust Inst Health Welf"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12916-017-0890-9","article-title":"Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options","volume":"15","author":"Bardin","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0016","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nrrheum.2016.102","article-title":"Insight into rheumatological cause and effect through the use of Mendelian randomization","volume":"12","author":"Robinson","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0017","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10654-014-9927-y","article-title":"Determinants of the prevalence of gout in the general population: a systematic review and meta-regression","volume":"30","author":"Wijnands","year":"2015","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0018","unstructured":"Australian Bureau of Statistics. Australian bureau of statistics, Australian Government n.d. https:\/\/www.abs.gov.au\/. (accessed July 03, 2020)"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0019","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12889-017-4041-1","article-title":"Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: a systematic review","volume":"17","author":"Ranasinghe","year":"2017","journal-title":"BMC Public Health"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0020","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1445-5994.2012.02794.x","article-title":"Systematic review of the prevalence of gout and hyperuricaemia in Australia","volume":"42","author":"Robinson","year":"2012","journal-title":"Intern Med J"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1753-6405.1980.tb00263.x","article-title":"Serum lipids and other coronary risk factors in Sydney blood donors: a comparison with other Australian subjects","volume":"4","author":"Brennan","year":"1980","journal-title":"Community Health Stud"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0022","unstructured":"Australian Bureau of Statistics. National health survey: users\u2019 guide, 2017-18 2019. https:\/\/www.abs.gov.au\/ausstats\/abs@.nsf\/Lookup\/by%20Subject\/4363.0~2017-18~Main%20Features~Arthritis~24 (accessed August 21, 2020)."},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0023","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0024","unstructured":"Department of Veterans\u2019 Affairs n.d. https:\/\/www.dva.gov.au\/ (accessed July 27, 2020)."},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0025","unstructured":"Health AGD of. Australian Government Department of Health. Aust Gov Dep Health 2020. https:\/\/www.health.gov.au\/home."},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0026","unstructured":"Arthritis Australia - Creating Hope in Australians with Arthritis. Arthritis Aust n.d. https:\/\/arthritisaustralia.com.au\/ (accessed July 25, 2020)."},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0027","unstructured":"Arthritis Care, Osteoarthritis, about arthritis | Arthritis foundation of WA. Arthritis WA n.d. https:\/\/www.arthritiswa.org.au\/ (accessed July 24, 2020)."},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0028","unstructured":"Arthritis Queensland - Home. Arthritis Qld n.d. https:\/\/www.arthritis.org.au\/ (accessed July 24, 2020)."},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0029","unstructured":"Arthritis & Osteoporosis Northern Territory (AONT). Arthritis Osteoporos NT n.d. https:\/\/www.aont.org.au\/ (accessed July 25, 2020)."},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0030","unstructured":"Arthritis NSW n.d. https:\/\/www.arthritisnsw.org.au\/ (accessed July 24, 2020)."},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0031","unstructured":"Arthritis ACT n.d. https:\/\/www.arthritisact.org.au\/ (accessed July 25, 2020)."},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0032","unstructured":"Arthritis & Osteoporosis Tasmania | Arthritis & osteoporosis Tasmania n.d. https:\/\/arthritistas.org.au\/ (accessed July 25, 2020)."},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0033","unstructured":"Musculoskeletal Australia (MSK). Musculoskelet Aust MSK n.d. https:\/\/www.msk.org.au\/ (accessed July 25, 2020)."},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0034","unstructured":"Bone and Joint Australia. Bone Jt Aust n.d. http:\/\/www.bjd.org.au\/ (accessed July 25, 2020)."},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0035","unstructured":"ARA - The Australian Rheumatology Association n.d. https:\/\/rheumatology.org.au\/ (accessed July 30, 2020)."},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0036","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12891-017-1496-2","article-title":"Associations between multimorbidity and additional burden for working-age adults with specific forms of musculoskeletal conditions: a cross-sectional study","volume":"18","author":"Lowe","year":"2017","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0037","unstructured":"Gout, What is gout? Aust Inst Health Welf n.d. https:\/\/www.aihw.gov.au\/reports\/chronic-musculoskeletal-conditions\/gout\/contents\/what-is-gout (accessed July 25, 2020)."},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0038","unstructured":"Australian Bureau of Statistics. TableBuilder n.d. https:\/\/tablebuilder.abs.gov.au\/webapi\/jsf\/login.xhtml. (accessed July 03, 2020)"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0039","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1471-2369-14-176","article-title":"The correlates of urinary albumin to creatinine ratio (ACR) in a high risk Australian aboriginal community","volume":"14","author":"Wang","year":"2013","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0040","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1111\/ajag.12716","article-title":"A profile of health status and demographics of aged care facility residents with gout","volume":"39","author":"Nguyen","year":"2020","journal-title":"Aust J Ageing"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0041","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12937-015-0032-1","article-title":"Cross-sectional analysis of nutrition and serum uric acid in two Caucasian cohorts: the AusDiab study and the Troms\u00f8 study","volume":"14","author":"Zykova","year":"2015","journal-title":"Nutr J"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0042","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13075-019-1918-7","article-title":"Gout, flares, and allopurinol use: a population-based study","volume":"21","author":"Proudman","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.136925","article-title":"Wastewater-based estimation of the prevalence of gout in Australia","volume":"715","author":"Ahmed","year":"2020","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0044","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13075-018-1633-9","article-title":"Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study","volume":"20","author":"Pisaniello","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0045","doi-asserted-by":"crossref","DOI":"10.3390\/pharmacy6040134","article-title":"Patterns of medication dispensation for multiple comorbidities among older adults in Australia","volume":"6","author":"Ofori-Asenso","year":"2018","journal-title":"Pharmacy"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0046","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12891-018-1941-x","article-title":"Epidemiology of arthritis, chronic back pain, gout, osteoporosis, spondyloarthropathies and rheumatoid arthritis among 1.5 million patients in Australian general practice: NPS medicine wise medicine insight dataset","volume":"19","author":"Gonz\u00e1lez-Chica","year":"2018","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0047","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3899\/jrheum.150310","article-title":"An observational study of gout prevalence and quality of care in a national Australian general practice population","volume":"42","author":"Robinson","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0048","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/imj.13006","article-title":"Prevalence and associations of gout and hyperuricaemia: results from an Australian population-based study","volume":"46","author":"Ting","year":"2016","journal-title":"Intern Med J"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0049","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12872-016-0421-1","article-title":"Asymptomatic hyperuricemia is not an independent risk factor for cardiovascular events or overall mortality in the general population of the Busselton health study","volume":"16","author":"Nossent","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0050","article-title":"Prevalence, incidence and years lived with disability due to gout and its attributable risk factors for 195 countries and territories 1990-2017: a systematic analysis of the Global Burden of Disease Study","author":"Safiri","year":"2017","journal-title":"Arthritis Rheumatol n.d"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0051","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/rheumatology\/kez196","article-title":"Gout and hyperuricaemia in the USA: prevalence and trends","volume":"58","author":"Singh","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0052","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/annrheumdis-2013-204463","article-title":"Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study","volume":"74","author":"Kuo","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0053","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/1756-185X.12941","article-title":"Epidemiology of inpatient gout in Australia and New Zealand: temporal trends, comorbidities and gout flare site","volume":"20","author":"Robinson","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0054","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3899\/jrheum.100418","article-title":"Reliability and sensitivity of the self-report of physician-diagnosed gout in the campaign against cancer and heart disease and the atherosclerosis risk in the community cohorts","volume":"38","author":"McAdams","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0055","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/acr.22896","article-title":"Survey definitions of gout for epidemiologic studies: comparison with crystal identification as the gold standard","volume":"68","author":"Dalbeth","year":"2016","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0056","doi-asserted-by":"crossref","DOI":"10.5694\/mja2.50512","article-title":"Time to recognise gout as a chronic disease","volume":"212","author":"Keen","year":"2020","journal-title":"Med J Aust"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0057","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1136\/annrheumdis-2012-201687","article-title":"Gout: why is this curable disease so seldom cured?","volume":"71","author":"Doherty","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0058","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033726","article-title":"What factors contribute to uncontrolled gout and hospital admission? A qualitative study of inpatients and their primary care practitioners","volume":"9","author":"Kong","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0059","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/rheumatology\/kes147","article-title":"Potential unmet need for gout diagnosis and treatment: capture\u2013recapture analysis of a national administrative dataset","volume":"51","author":"Jackson","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0060","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.trac.2018.06.004","article-title":"Wastewater-based epidemiology biomarkers: past, present and future","volume":"105","author":"Choi","year":"2018","journal-title":"TrAC Trends Anal Chem"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0061","unstructured":"WHOCC. Guidelines for ATC classification and DDD assignment 2020 n.d. https:\/\/www.whocc.no\/atc_ddd_index\/ (accessed August 31, 2020)."},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0062","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/phar.2341","article-title":"Medication use for comorbidities in people with alzheimer's disease: an australian population-based study","volume":"39","author":"Eshetie","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0063","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s40266-017-0512-4","article-title":"Managing gout flares in the elderly: practical considerations","volume":"34","author":"Abhishek","year":"2017","journal-title":"Drugs Aging"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0064","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/jppr.1511","article-title":"Management of gout in older people","volume":"49","author":"Day","year":"2019","journal-title":"J Pharm Pract Res"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0065","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3899\/jrheum.160300","article-title":"The direct economic burden of gout in an elderly Canadian population","volume":"44","author":"Fischer","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0066","doi-asserted-by":"crossref","DOI":"10.1111\/imj.12107","article-title":"Gouty arthritis in Australian aborigines","volume":"43","author":"Douglas","year":"2013","journal-title":"Intern Med J"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0067","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/imj.12094","article-title":"Author reply","volume":"43","author":"Robinson","year":"2013","journal-title":"Intern Med J"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0068","first-page":"965","article-title":"Rheumatic disease in an Australian aboriginal community in North Queensland, Australia. A WHO-ILAR COPCORD survey","volume":"31","author":"Minaur","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0069","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12939-017-0610-2","article-title":"Healthcare expenditure on Indigenous and non-indigenous Australians at high risk of cardiovascular disease","volume":"16","author":"Angell","year":"2017","journal-title":"Int J Equity Health"},{"key":"10.1016\/j.semarthrit.2020.12.001_bib0070","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/art.40807","article-title":"Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the national health and nutrition examination survey 2007-2016","volume":"71","author":"Chen-Xu","year":"2019","journal-title":"Arthritis Rheumatol Hoboken NJ"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901722030281X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901722030281X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:04:34Z","timestamp":1758733474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004901722030281X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S004901722030281X"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.12.001","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prevalence of gout and hyperuricaemia in Australia: An updated systematic review","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}